Roche’s Enspryng is making solid progress as a treatment for neuromyelitis optica spectrum disorder. But the company’s efforts to expand its use to a new indication is coming up short.
With the Supreme Court’s rebuke of President Donald Trump’s emergency tariffs Friday, the U.S. administration’s international trade agenda is facing a new threat. At least one major partner has pumped the brakes on a deal that the president’s import taxes helped facilitate last summer.
Bayer has filed a false advertising lawsuit taking issue with claims made by Johnson & Johnson to pit their prostate cancer drugs against one another.
With a productive working relationship between the two companies already well established, Bora Pharmaceuticals is renewing a $250 million global manufacturing agreement with British drugmaker GSK.
Vanda Pharmaceuticals is riding a regulatory roller coaster over the last few months with two FDA approvals and one rejection. On Friday, the U.S. regulator signed off on Vanda's Bysanti, an atypical antipsychotic treatment for schizophrenia and bipolar I disorder.
Gilead Sciences is buying Arcellx in a deal worth $7.8 billion, picking up its partner on a CAR-T therapy for multiple myeloma.
Novo Nordisk's next-generation obesity drug CagriSema underperformed versus Eli Lilly's Zepbound in a head-to-head study.
The smaller arteries of women means a little plaque can be more dangerous than it is for men.
People whose sugar intake was restricted before birth and in early childhood had markedly lower rates of heart disease later in life. Compared to those never exposed to rationing, their risks of heart attack, stroke, heart failure, and cardiovascular death were cut by roughly 20–30%.
Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common allergens. Instead of targeting a specific virus or bacterium, the nasal spray vaccine supercharges the lungs’ own immune defenses, keeping them on high alert for months. In mice, it slashed viral levels,
Babies born in the early 2000s were exposed in the womb to far more “forever chemicals” than researchers once realized, according to a new study. By using advanced chemical screening on umbilical cord blood, scientists detected 42 different PFAS compounds, including many that standard tests do not routinely check for. These long lasting chemicals are found in common products like nonstick cookware
Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to four years. The protein mirrors the silent buildup of amyloid and tau in the brain long before memory loss appears. This advance could speed up preventive drug trials and eventually guide personalized
A sweeping new scientific review suggests that pecans — America’s native nut — may pack more heart power than many people realize. After analyzing over 20 years of research, scientists found consistent evidence that eating pecans can improve key markers of cardiovascular health, including total cholesterol and “bad” LDL cholesterol, while also supporting antioxidant defenses.
Chronic wounds often spiral out of control because oxygen can’t reach the deepest layers of injured tissue. A new gel developed at UC Riverside delivers a continuous flow of oxygen right where it’s needed most, using a tiny battery-powered system. In high-risk mice, wounds healed in weeks instead of worsening. The innovation could dramatically reduce amputations—and may even open doors for lab-gro
Deep inside a Romanian ice cave, locked away in a 5,000-year-old layer of ice, scientists have uncovered a bacterium with a startling secret: it’s resistant to many modern antibiotics. Despite predating the antibiotic era, this cold-loving microbe carries more than 100 resistance-related genes and can survive drugs used today to treat serious infections like tuberculosis and UTIs.
Researchers have mapped the genetic risk of hemochromatosis across the UK and Ireland for the first time, uncovering striking hotspots in north-west Ireland and the Outer Hebrides. In some regions, around one in 60 people carry the high-risk gene variant linked to iron overload. The condition can take decades to surface but may lead to liver cancer and arthritis if untreated.
Living at high altitude appears to protect against diabetes, and scientists have finally discovered the reason. When oxygen levels drop, red blood cells switch into a new metabolic mode and absorb large amounts of glucose from the blood. This helps the body cope with thin air while also reducing blood sugar levels. A drug that recreates this effect reversed diabetes in mice, hinting at a powerful
Running extreme distances may strain more than just muscles and joints. New research suggests ultramarathons can alter red blood cells in ways that make them less flexible and more prone to breakdown, potentially interfering with how they deliver oxygen throughout the body. Scientists found signs of both mechanical stress from intense blood flow and molecular damage linked to inflammation and oxid
Researchers tested whether generative AI could handle complex medical datasets as well as human experts. In some cases, the AI matched or outperformed teams that had spent months building prediction models. By generating usable analytical code from precise prompts, the systems dramatically reduced the time needed to process health data. The findings hint at a future where AI helps scientists move
Nature Medicine starts an investigation into inconsistencies in a study that found it was better to have immunotherapy in the morning.